Clearmind Medicine Inc., a clinical stage pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. The company develops treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression. It develops MEAI compound for the treatment of alcohol use disorder, obesity, and metabolic disorders, as well as an alcohol substitute consumer product; and CM-CMND-001 which is in Phase I/IIa clinical trial for the treatment of alcohol use disorder. In addition, the company has a strategic collaboration with SciSparc Ltd., Yissum Research Development Company of the Hebrew University of Jerusalem, Polyrizon Ltd., and NeuroThera Labs Inc. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. The company was incorporated in 2017 and is headquartered in Vancouver, Canada.
Frequently asked questions
What sector does Clearmind Medicine Inc. Common Shares (CMND) operate in?
Clearmind Medicine Inc. Common Shares belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Clearmind Medicine Inc. Common Shares (CMND) current stock price?
As of the latest data, Clearmind Medicine Inc. Common Shares stock price is $1.96, with a previous close of $1.89. Clearmind Medicine Inc. Common Shares gained $0.07 in the last trading session, representing a 3.7% increase.
What is Clearmind Medicine Inc. Common Shares (CMND) current market capitalization?
Clearmind Medicine Inc. Common Shares market cap is approximately 2.91 million.
What is Clearmind Medicine Inc. Common Shares (CMND) Earnings Per Share (EPS)?
The trailing EPS is -$175.92.
What is Clearmind Medicine Inc. Common Shares (CMND) EBITDA?
Clearmind Medicine Inc. Common Shares EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -1.56 million.
Does Clearmind Medicine Inc. Common Shares (CMND) pay dividends?
No. Clearmind Medicine Inc. Common Shares does not pay a dividend.
When is Clearmind Medicine Inc. Common Shares (CMND) next earnings report?
Clearmind Medicine Inc. Common Shares is expected to release its next earnings report on July 31, 2026.
What is Clearmind Medicine Inc. Common Shares (CMND) beta (volatility) score?
Clearmind Medicine Inc. Common Shares has a beta of -1.191, indicating lower volatility than the overall market.
